IFNα2 is used to treat patients with several malignant diseases such as hairy cell leukemia, lymphoma, renal cell carcinoma, bladder cancer, breast cancer, and melanoma (Borden 1984, Kirkwood 2002). This evidence concerns the gene IFNA2 and renal cell carcinoma.